Is Germany Set To Become Next Cannabis Giant? ‘We Tripled Within One Year,’ Says Industry Insider

The Benzinga Cannabis Capital Conference brought together global cannabis leaders, including Finn Hänsel, managing director and founder of Sanity Group.

Sanity Group is one of the leading cannabis companies in Germany, focusing on medicinal cannabis, CBD wellness products, and adult-use cannabis. With Germany’s recent regulatory changes, Hänsel highlighted the company’s strategy for navigating the rapidly expanding European cannabis market.

The Impact of Germany’s New Cannabis Law

Germany’s landmark cannabis bill, the Cannabis Control Act (CanG), which took effect in April, is a pivotal moment for the European cannabis market. As Hänsel described, this change is already driving substantial growth. “Just to give an example, we did 1 million euros in revenue in January. Now, in October, we’re probably doing three. So we tripled within one year just because of this regulatory change,” Hänsel said, illustrating the transformative impact of Germany’s relaxed regulations on medical cannabis.

Hänsel emphasized the potential for an even larger shift, predicting an increase in the number of cannabis patients in Germany. “We have 0.2% of the population that …

Full story available on Benzinga.com